GoAI
Get started
EuroEyes International Eye Clinic Limited logo

EuroEyes International Eye Clinic Limited

1846.HK

HKSEHealthcareMedical - Care Facilities

Open in GoAI

Latest quote

HK$2.50

+HK$0.02 · +0.81%

Aug 20, 3:00 PM HKTData delayed

1846.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

EuroEyes International Eye Clinic Limited provides vision correction services in Germany, the People’s Republic of China, Denmark, and the United Kingdom. The company offers laser eye surgery in various options, including SMILE Pro, Femto-Lasik, PRK, and Lasek; refractive laser surgery, such as ReLEx SMILE, Femto LASIK, and Presbyond; lens exchange surgery comprising monofocal and trifocal lens exchange surgery; and PRK/LASEK and ICRS implantation services. It also sells pharmaceutical products; rental of ophthalmic equipment and operating spaces; and provides training service. In addition, the company is involved in the operation of consultation centers and/or clinics for eye treatment, as well as LASIK centers; and trading of eye clinic equipment and lenses. EuroEyes International Eye Clinic Limited was founded in 1993 and is headquartered in Hamburg, Germany.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
DE
CEO
Jørn Slot Jørgensen
Listed since
Oct 15, 2019
Employees
352

Market position

Day range

Current HK$2.50

52-week range

Current HK$2.50

Open
HK$2.51
Previous close
HK$2.48
Volume
5K
0.08× average
Average volume
59.8K
Average daily volume
Market cap
798.76M HKD
Beta
0.34
Market reference 1
50-day average
HK$2.4723
+1.12% above average
200-day average
HK$2.7816
-10.12% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
685.7M HKD
P/E (TTM)
14.69×
P/B (TTM)
0.64×
P/S (TTM)
1×
EV / EBITDA
4.19×
Earnings yield
5.60%
Free cash flow yield
15.23%
Dividend yield
1.76%

Profitability & efficiency

Gross margin
40.74%
Operating margin
14.40%
Net margin
6.84%
Return on equity
4.36%
Return on assets
2.79%
Return on invested capital
3.60%

Financial health

Debt / equity
0.33×
Current ratio
2.79×
Altman Z-score
2.58
Piotroski F-score
6 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends54%37%20%3%Gross margin, FY2021: 49.38%Gross margin, FY2022: 44.38%Gross margin, FY2023: 46.97%Gross margin, FY2024: 40.04%Gross margin, FY2025: 40.74%Operating margin, FY2021: 30.22%Operating margin, FY2022: 21.76%Operating margin, FY2023: 27.09%Operating margin, FY2024: 16.18%Operating margin, FY2025: 14.40%Net margin, FY2021: 21.10%Net margin, FY2022: 14.66%Net margin, FY2023: 18.37%Net margin, FY2024: 11.50%Net margin, FY2025: 6.84%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 49.38%. Gross margin FY2022 44.38%. Gross margin FY2023 46.97%. Gross margin FY2024 40.04%. Gross margin FY2025 40.74%. Operating margin FY2021 30.22%. Operating margin FY2022 21.76%. Operating margin FY2023 27.09%. Operating margin FY2024 16.18%. Operating margin FY2025 14.40%. Net margin FY2021 21.10%. Net margin FY2022 14.66%. Net margin FY2023 18.37%. Net margin FY2024 11.50%. Net margin FY2025 6.84%.

Income trends

Revenue

796.04M HKD+11.23%

Operating income

114.63M HKD-0.99%

Net income

54.45M HKD-33.83%
Income trends across reported periods870.2M HKD573.56M HKD276.93M HKD−19.71M HKDRevenue, FY2021: 632.93M HKDRevenue, FY2022: 610.29M HKDRevenue, FY2023: 714.29M HKDRevenue, FY2024: 715.68M HKDRevenue, FY2025: 796.04M HKDOperating income, FY2021: 191.26M HKDOperating income, FY2022: 132.81M HKDOperating income, FY2023: 193.51M HKDOperating income, FY2024: 115.78M HKDOperating income, FY2025: 114.63M HKDNet income, FY2021: 133.56M HKDNet income, FY2022: 89.47M HKDNet income, FY2023: 131.24M HKDNet income, FY2024: 82.29M HKDNet income, FY2025: 54.45M HKDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 632.93M HKD. Revenue FY2022 610.29M HKD. Revenue FY2023 714.29M HKD. Revenue FY2024 715.68M HKD. Revenue FY2025 796.04M HKD. Operating income FY2021 191.26M HKD. Operating income FY2022 132.81M HKD. Operating income FY2023 193.51M HKD. Operating income FY2024 115.78M HKD. Operating income FY2025 114.63M HKD. Net income FY2021 133.56M HKD. Net income FY2022 89.47M HKD. Net income FY2023 131.24M HKD. Net income FY2024 82.29M HKD. Net income FY2025 54.45M HKD.
Metric (HKD)FY2025FY2024FY2023FY2022FY2021
Revenue796.04M HKD715.68M HKD714.29M HKD610.29M HKD632.93M HKD
Cost of goods sold471.71M HKD429.09M HKD378.77M HKD339.45M HKD320.39M HKD
Gross profit324.33M HKD286.59M HKD335.52M HKD270.84M HKD312.55M HKD
Selling, general, and administrative209.48M HKD185.82M HKD95.98M HKD77.89M HKD82.22M HKD
Operating expenses209.7M HKD170.81M HKD142.01M HKD138.04M HKD121.3M HKD
Interest income13.36M HKD23.57M HKD19.33M HKD1.14M HKD138K HKD
Interest expense11.48M HKD15.79M HKD14.14M HKD10.74M HKD8.47M HKD
Depreciation and amortization47.13M HKD37.18M HKD87.35M HKD80.72M HKD74.66M HKD
Operating income114.63M HKD115.78M HKD193.51M HKD132.81M HKD191.26M HKD
Net income54.45M HKD82.29M HKD131.24M HKD89.47M HKD133.56M HKD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
100%
2 beats, 0 misses, 0 met estimates
Average EPS surprise
+452.46%
2 comparable reports
Latest EPS result
0.05

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.250.180.110.03Q3 '22BeatQ1 '23No estimateQ3 '23No estimateQ1 '24No estimateQ3 '24No estimateQ1 '25No estimateQ3 '25No estimateQ1 '26No estimate
Q3 2022, reported Aug 24, 2022: actual 0.14, estimate 0.04, surprise +250.25%, Beat. Q1 2023, reported Mar 28, 2023: actual 0.13, estimate —, surprise —, Comparison unavailable. Q3 2023, reported Aug 29, 2023: actual 0.212, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Mar 28, 2024: actual 0.188, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 27, 2024: actual 0.188, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 31, 2025: actual 0.12, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Sep 1, 2025: actual 0.121, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 31, 2026: actual 0.05, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates1.02B763.31M506.89M250.47MQ1 '23MissQ3 '23MissQ1 '24MissQ3 '24MissQ1 '25No estimateQ3 '25No estimateQ1 '26No estimateQ3 '26Estimate
Q1 2023, reported Mar 28, 2023: actual 294.67M HKD, estimate 966.03M HKD, surprise -69.50%, Miss. Q3 2023, reported Aug 29, 2023: actual 346.38M HKD, estimate 875.12M HKD, surprise -60.42%, Miss. Q1 2024, reported Mar 28, 2024: actual 369.69M HKD, estimate 875.12M HKD, surprise -57.76%, Miss. Q3 2024, reported Aug 27, 2024: actual 368.37M HKD, estimate 875.12M HKD, surprise -57.91%, Miss. Q1 2025, reported Mar 31, 2025: actual 347.31M HKD, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Sep 1, 2025: actual 377.13M HKD, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 31, 2026: actual 418.92M HKD, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 31, 2026: actual —, estimate 432.68M HKD, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

HK$0.0612

2025 complete year-46.2% since 2023

2026 partial: HK$0.0126

* Partial calendar year in the available dividend history.

Corporate action history

Dividend

Ex-dividend Jul 3, 2026

HK$0.0126

Semi-Annual

Record Jul 6, 2026 · Payment Jul 24, 2026

Dividend

Ex-dividend Sep 26, 2025

HK$0.0315

Semi-Annual

Record Sep 30, 2025 · Payment Oct 17, 2025

Dividend

Ex-dividend Jun 10, 2025

HK$0.0297

Semi-Annual

Record Jun 12, 2025 · Payment Jun 27, 2025

Dividend

Ex-dividend Sep 27, 2024

HK$0.0349

Semi-Annual

Record Oct 2, 2024 · Payment Oct 18, 2024

Dividend

Ex-dividend Jun 11, 2024

HK$0.0489

Semi-Annual

Record Jun 13, 2024 · Payment Jun 28, 2024

Dividend

Ex-dividend Sep 11, 2023

HK$0.0511

Semi-Annual

Record Sep 13, 2023 · Payment Sep 28, 2023

1846.HK peers

WuXi AppTec Co., Ltd. logo

2359.HK

WuXi AppTec Co., Ltd.

HK$197.1

-4.23%

Jiangsu Hengrui Pharmaceuticals Co.,Ltd logo

1276.HK

Jiangsu Hengrui Pharmaceuticals Co.,Ltd

HK$46.74

-3.03%

BeOne Medicines AG logo

6160.HK

BeOne Medicines AG

HK$222.2

-2.54%

WuXi Biologics (Cayman) Inc. logo

2269.HK

WuXi Biologics (Cayman) Inc.

HK$48.40

-5.10%

Hansoh Pharmaceutical Group Company Limited logo

3692.HK

Hansoh Pharmaceutical Group Company Limited

HK$31.34

-5.26%

Innovent Biologics, Inc. logo

1801.HK

Innovent Biologics, Inc.

HK$99.35

-2.98%

Continue in GoAI

Research 1846.HK

research.disclaimer